Agricultural Farm Products
Compare Stocks
5 / 10Stock Comparison
SANW vs BG vs ADM vs INGR vs CTVA
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Farm Products
Agricultural Farm Products
Packaged Foods
Agricultural Inputs
SANW vs BG vs ADM vs INGR vs CTVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Agricultural Farm Products | Agricultural Farm Products | Agricultural Farm Products | Packaged Foods | Agricultural Inputs |
| Market Cap | $43K | $24.02B | $37.36B | $6.77B | $53.08B |
| Revenue (TTM) | $38M | $80.54B | $80.61B | $7.22B | $17.89B |
| Net Income (TTM) | $-32M | $686M | $1.08B | $729M | $1.16B |
| Gross Margin | 20.9% | 5.2% | 5.8% | 25.3% | 33.5% |
| Operating Margin | -44.5% | 2.4% | 1.5% | 14.1% | 13.8% |
| Forward P/E | — | 14.4x | 18.6x | 9.6x | 21.6x |
| Total Debt | $54M | $16.95B | $8.41B | $1.79B | $2.58B |
| Cash & Equiv. | $294K | $1.14B | $1.01B | $1.03B | $4.52B |
SANW vs BG vs ADM vs INGR vs CTVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| S&W Seed Company (SANW) | 100 | 0.0 | -100.0% |
| Bunge Global S.A. (BG) | 100 | 317.3 | +217.3% |
| Archer-Daniels-Midl… (ADM) | 100 | 197.2 | +97.2% |
| Ingredion Incorpora… (INGR) | 100 | 127.5 | +27.5% |
| Corteva, Inc. (CTVA) | 100 | 289.5 | +189.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SANW vs BG vs ADM vs INGR vs CTVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SANW lags the leaders in this set but could rank higher in a more targeted comparison.
BG is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 32.4%, EPS growth -38.4%, 3Y rev CAGR 1.5%
- 32.4% revenue growth vs SANW's -17.8%
- +66.8% vs SANW's -99.6%
ADM ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 31 yrs, beta 0.12, yield 2.6%
- Lower volatility, beta 0.12, Low D/E 36.5%, current ratio 11.20x
- Beta 0.12, yield 2.6%, current ratio 11.20x
- Beta 0.12 vs CTVA's 0.29
INGR carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 0.57 vs CTVA's 1.81
- Lower P/E (9.6x vs 21.6x), PEG 0.57 vs 1.81
- 10.1% margin vs SANW's -85.4%
- 3.0% yield, 3-year raise streak, vs ADM's 2.6%, (1 stock pays no dividend)
CTVA is the clearest fit if your priority is long-term compounding.
- 186.7% 10Y total return vs ADM's 147.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.4% revenue growth vs SANW's -17.8% | |
| Value | Lower P/E (9.6x vs 21.6x), PEG 0.57 vs 1.81 | |
| Quality / Margins | 10.1% margin vs SANW's -85.4% | |
| Stability / Safety | Beta 0.12 vs CTVA's 0.29 | |
| Dividends | 3.0% yield, 3-year raise streak, vs ADM's 2.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +66.8% vs SANW's -99.6% | |
| Efficiency (ROA) | 9.4% ROA vs SANW's -46.3%, ROIC 15.5% vs -12.0% |
SANW vs BG vs ADM vs INGR vs CTVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SANW vs BG vs ADM vs INGR vs CTVA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INGR leads in 2 of 6 categories
BG leads 1 • SANW leads 0 • ADM leads 0 • CTVA leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
INGR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ADM is the larger business by revenue, generating $80.6B annually — 2134.8x SANW's $38M. INGR is the more profitable business, keeping 10.1% of every revenue dollar as net income compared to SANW's -85.4%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $38M | $80.5B | $80.6B | $7.2B | $17.9B |
| EBITDAEarnings before interest/tax | -$14M | $2.8B | $3.0B | $1.2B | $3.4B |
| Net IncomeAfter-tax profit | -$32M | $686M | $1.1B | $729M | $1.2B |
| Free Cash FlowCash after capex | $497,701 | $112M | $4.8B | $809M | $2.1B |
| Gross MarginGross profit ÷ Revenue | +20.9% | +5.2% | +5.8% | +25.3% | +33.5% |
| Operating MarginEBIT ÷ Revenue | -44.5% | +2.4% | +1.5% | +14.1% | +13.8% |
| Net MarginNet income ÷ Revenue | -85.4% | +0.9% | +1.3% | +10.1% | +6.5% |
| FCF MarginFCF ÷ Revenue | +1.3% | +0.1% | +6.0% | +11.2% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +87.8% | +1.6% | -2.4% | +11.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +57.7% | -76.4% | +1.6% | +79.0% | +12.6% |
Valuation Metrics
Evenly matched — SANW and INGR each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 9.6x trailing earnings, INGR trades at a 81% valuation discount to CTVA's 49.4x P/E. Adjusting for growth (PEG ratio), INGR offers better value at 0.57x vs CTVA's 4.14x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $43,117 | $24.0B | $37.4B | $6.8B | $53.1B |
| Enterprise ValueMkt cap + debt − cash | $54M | $39.8B | $44.8B | $7.5B | $51.1B |
| Trailing P/EPrice ÷ TTM EPS | -0.00x | 25.16x | 34.77x | 9.61x | 49.42x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.38x | 18.63x | 9.56x | 21.57x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.57x | 4.14x |
| EV / EBITDAEnterprise value multiple | — | 22.60x | 17.18x | 5.98x | 13.38x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 0.34x | 0.47x | 0.94x | 3.05x |
| Price / BookPrice ÷ Book value/share | 0.00x | 1.18x | 1.63x | 1.60x | 2.18x |
| Price / FCFMarket cap ÷ FCF | — | — | 8.89x | 13.25x | 18.86x |
Profitability & Efficiency
INGR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
INGR delivers a 17.1% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-120 for SANW. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to SANW's 1.21x. On the Piotroski fundamental quality scale (0–9), INGR scores 8/9 vs BG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -120.2% | +4.3% | +4.7% | +17.1% | +4.6% |
| ROA (TTM)Return on assets | -46.3% | +1.6% | +2.2% | +9.4% | +2.7% |
| ROICReturn on invested capital | -12.0% | +3.3% | +3.3% | +15.5% | +8.5% |
| ROCEReturn on capital employed | -26.8% | +4.5% | +4.2% | +16.3% | +8.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 | 6 | 8 | 6 |
| Debt / EquityFinancial leverage | 1.21x | 0.97x | 0.37x | 0.41x | 0.11x |
| Net DebtTotal debt minus cash | $54M | $15.8B | $7.4B | $760M | -$1.9B |
| Cash & Equiv.Liquid assets | $294,014 | $1.1B | $1.0B | $1.0B | $4.5B |
| Total DebtShort + long-term debt | $54M | $17.0B | $8.4B | $1.8B | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | -3.41x | 3.10x | 3.03x | 27.32x | 5.82x |
Total Returns (Dividends Reinvested)
BG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTVA five years ago would be worth $16,828 today (with dividends reinvested), compared to $3 for SANW. Over the past 12 months, BG leads with a +66.8% total return vs SANW's -99.6%. The 3-year compound annual growth rate (CAGR) favors BG at 13.5% vs SANW's -90.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -71.3% | +34.4% | +32.2% | -0.7% | +17.0% |
| 1-Year ReturnPast 12 months | -99.6% | +66.8% | +66.2% | -18.4% | +27.7% |
| 3-Year ReturnCumulative with dividends | -99.9% | +46.3% | +10.7% | +7.9% | +40.8% |
| 5-Year ReturnCumulative with dividends | -100.0% | +49.4% | +29.2% | +28.8% | +68.3% |
| 10-Year ReturnCumulative with dividends | -100.0% | +140.3% | +147.4% | +13.5% | +186.7% |
| CAGR (3Y)Annualised 3-year return | -90.8% | +13.5% | +3.4% | +2.6% | +12.1% |
Risk & Volatility
Evenly matched — SANW and ADM each lead in 1 of 2 comparable metrics.
Risk & Volatility
SANW is the less volatile stock with a -3.79 beta — it tends to amplify market swings less than CTVA's 0.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ADM currently trades 94.8% from its 52-week high vs SANW's 0.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -3.79x | 0.25x | 0.12x | 0.25x | 0.29x |
| 52-Week HighHighest price in past year | $6.00 | $133.93 | $81.75 | $141.78 | $85.63 |
| 52-Week LowLowest price in past year | $0.00 | $71.60 | $46.81 | $100.71 | $60.54 |
| % of 52W HighCurrent price vs 52-week peak | +0.3% | +92.4% | +94.8% | +75.8% | +92.3% |
| RSI (14)Momentum oscillator 0–100 | 28.6 | 51.8 | 68.4 | 27.3 | 53.3 |
| Avg Volume (50D)Average daily shares traded | 686 | 1.7M | 3.8M | 585K | 3.4M |
Analyst Outlook
Evenly matched — ADM and INGR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BG as "Buy", ADM as "Hold", INGR as "Hold", CTVA as "Buy". Consensus price targets imply 15.7% upside for INGR (target: $124) vs -22.6% for ADM (target: $60). For income investors, INGR offers the higher dividend yield at 3.01% vs CTVA's 0.89%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $133.67 | $60.00 | $124.25 | $88.17 |
| # AnalystsCovering analysts | — | 25 | 36 | 21 | 37 |
| Dividend YieldAnnual dividend ÷ price | — | +2.2% | +2.6% | +3.0% | +0.9% |
| Dividend StreakConsecutive years of raises | — | 5 | 31 | 3 | 5 |
| Dividend / ShareAnnual DPS | — | $2.76 | $2.04 | $3.24 | $0.71 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.3% | 0.0% | +3.3% | +2.0% |
INGR leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BG leads in 1 (Total Returns). 3 tied.
SANW vs BG vs ADM vs INGR vs CTVA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SANW or BG or ADM or INGR or CTVA a better buy right now?
For growth investors, Bunge Global S.
A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -17. 8% for S&W Seed Company (SANW). Ingredion Incorporated (INGR) offers the better valuation at 9. 6x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Bunge Global S. A. (BG) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SANW or BG or ADM or INGR or CTVA?
On trailing P/E, Ingredion Incorporated (INGR) is the cheapest at 9.
6x versus Corteva, Inc. at 49. 4x. On forward P/E, Ingredion Incorporated is actually cheaper at 9. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Ingredion Incorporated wins at 0. 57x versus Corteva, Inc. 's 1. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SANW or BG or ADM or INGR or CTVA?
Over the past 5 years, Corteva, Inc.
(CTVA) delivered a total return of +68. 3%, compared to -100. 0% for S&W Seed Company (SANW). Over 10 years, the gap is even starker: CTVA returned +186. 7% versus SANW's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SANW or BG or ADM or INGR or CTVA?
By beta (market sensitivity over 5 years), S&W Seed Company (SANW) is the lower-risk stock at -3.
79β versus Corteva, Inc. 's 0. 29β — meaning CTVA is approximately -108% more volatile than SANW relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 121% for S&W Seed Company — giving it more financial flexibility in a downturn.
05Which is growing faster — SANW or BG or ADM or INGR or CTVA?
By revenue growth (latest reported year), Bunge Global S.
A. (BG) is pulling ahead at 32. 4% versus -17. 8% for S&W Seed Company (SANW). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to -317. 7% for S&W Seed Company. Over a 3-year CAGR, BG leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SANW or BG or ADM or INGR or CTVA?
Ingredion Incorporated (INGR) is the more profitable company, earning 10.
1% net margin versus -49. 7% for S&W Seed Company — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTVA leads at 15. 1% versus -29. 3% for SANW. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SANW or BG or ADM or INGR or CTVA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Ingredion Incorporated (INGR) is the more undervalued stock at a PEG of 0. 57x versus Corteva, Inc. 's 1. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Ingredion Incorporated (INGR) trades at 9. 6x forward P/E versus 21. 6x for Corteva, Inc. — 12. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INGR: 15. 7% to $124. 25.
08Which pays a better dividend — SANW or BG or ADM or INGR or CTVA?
In this comparison, INGR (3.
0% yield), ADM (2. 6% yield), BG (2. 2% yield), CTVA (0. 9% yield) pay a dividend. SANW does not pay a meaningful dividend and should not be held primarily for income.
09Is SANW or BG or ADM or INGR or CTVA better for a retirement portfolio?
For long-horizon retirement investors, S&W Seed Company (SANW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -3.
79)). Both have compounded well over 10 years (SANW: -100. 0%, INGR: +13. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SANW and BG and ADM and INGR and CTVA?
These companies operate in different sectors (SANW (Consumer Defensive) and BG (Consumer Defensive) and ADM (Consumer Defensive) and INGR (Consumer Defensive) and CTVA (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SANW is a small-cap quality compounder stock; BG is a mid-cap high-growth stock; ADM is a mid-cap quality compounder stock; INGR is a small-cap deep-value stock; CTVA is a mid-cap quality compounder stock. BG, ADM, INGR, CTVA pay a dividend while SANW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 43%
- Dividend Yield > 0.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.